First Horizon Advisors, Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
First Horizon Advisors, Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$74,117
-42.3%
2,344
-25.6%
0.00%
-25.0%
Q2 2023$128,456
+2.9%
3,150
-6.0%
0.00%0.0%
Q1 2023$124,854
+6.7%
3,350
-0.1%
0.00%0.0%
Q4 2022$117,055
-36.0%
3,355
+2.4%
0.00%
-42.9%
Q3 2022$183,000
+1.1%
3,275
-6.7%
0.01%
+16.7%
Q2 2022$181,000
+16.8%
3,511
+164.6%
0.01%
+20.0%
Q4 2021$155,000
-4.9%
1,327
+8.7%
0.01%0.0%
Q3 2021$163,000
+1.9%
1,221
+22.5%
0.01%
-44.4%
Q2 2021$160,000
+97.5%
997
-2.2%
0.01%
+80.0%
Q1 2021$81,0001,0190.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 744,160$54,078,0005.79%
Discovery Value Fund 986,173$71,665,0005.28%
Ally Bridge Group (NY) LLC 60,000$4,360,0003.23%
MPM BioImpact LLC 159,409$11,584,0003.11%
ARK Investment Management 8,981,029$652,651,0002.72%
Elmwood Wealth Management, Inc. 67,599$4,912,0002.52%
Nikko Asset Management Americas, Inc. 2,872,269$192,442,0001.41%
Frazier Life Sciences Management, L.P. 203,684$14,802,0001.26%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$8,098,0001.22%
Merlin Capital, Inc 11,575$841,0001.11%
View complete list of INTELLIA THERAPEUTICS INC shareholders